MedTrace Logo

Prospective Cohort of HIV/HBV-coinfected Patients in Europe

NCT04984772 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1107

Last updated 2023-12-01

No results posted yet for this study

Summary

The overall aim of the project is to establish an international multi-cohort research platform of HIV/HBV-coinfected individuals treated with tenofovir to improve our understanding of the determinants of treatment outcomes.

Conditions

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Gilles Wandeler, MD MSc · Insel Gruppe AG, University Hospital Bern

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-02
Primary Completion
2030-12-31
Completion
2030-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04984772 on ClinicalTrials.gov